Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-2,page-paged-2,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • AiCuris nominates team of researchers from the Universitätsklinikum Erlangen as one of the 2022 winners of AiCubator Resident Status, a corporate innovation accelerator initiative
    www.aicuris.com
  • Destiny Pharma: Interim results for the six months ended 30 June 2022
    www.destinypharma.com
  • iOmx Therapeutics appoints Professor Frances Balkwill to the Scientific Advisory Board
    www.iomx.com
  • Destiny Pharma announces positive update from European Medicine Agency (EMA) on NTCD-M3 Phase 3 development plans
    www.destinypharma.com
  • ABIVAX PHASE 2B STUDY RESULTS OF OBEFAZIMOD (ABX464) IN ULCERATIVE COLITIS PUBLISHED IN THE LANCET GASTROENTEROLOGY & HEPATOLOGY
    www.abivax.com
  • Spexis provides business update and announces financial results for the first half of 2022
    www.spexisbio.com
  • ABIVAX PUBLISHES A PROSPECTUS IN THE CONTEXT OF ITS CAPITAL INCREASE
    www.abivax.com
  • ABIVAX ANNOUNCES SUCCESSFUL OVERSUBSCRIBED EUR 49.2M CROSS-OVER FINANCING WITH TOP-TIER US AND EUROPEAN BIOTECH INVESTORS
    www.abivax.com
  • AiCuris appoints experienced business leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer
    www.aicuris.com
  • Carbios strengthens Executive Committee with the appointment of Pascal Bricout as Chief Strategy & Financial Officer
    www.carbios.com